HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griese, M. Articles by Hartl, D. Search for Related Content PubMed PubMed Citation Articles by Griese, M. Articles by Hartl, D.

Inhibition of airway proteases in cystic fibrosis lung disease

¹ Children’s Hospital of Ludwig Maximilians University, Munich, Germany, ² University of Alabama at Birmingham, Birmingham, AL, USA.

CORRESPONDENCE: M. Griese, Ludwig Maximilians University, Children’s Hospital, Lindwurmstr. 4, D-80337 Munich, Germany. Fax: 49 8951607872. E-mail: matthias.griese{at}med.uni-muenchen.de

Keywords: Antiproteases, antitrypsin, cystic fibrosis, elastase, lung disease, proteases

Received: November 5, 2007
Accepted March 31, 2008

Progressive lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients.

CF lung disease is characterised by endobronchial inflammation sustained by bacterial infections and an ongoing accumulation of airway neutrophils. Activated or necrotic neutrophils liberate proteases that cause damage to structural, cellular and soluble components of the pulmonary microenvironment.

Among various proteases released by airway cells, elastase is considered to play the major role in CF lung disease. Based on this concept, several therapeutic approaches have been developed to inhibit free elastolytic activity, including small synthetic chemical compounds, semi-synthetic inhibitors and natural inhibitors of free elastase.

The present review summarises and discusses the pathophysiological rationales, methodological requirements and clinical implications of inhibition of airway proteases in cystic fibrosis lung disease.

This article has been cited by other articles:

				P. D. Sly, S. Brennan, C. Gangell, N. de Klerk, C. Murray, L. Mott, S. M. Stick, P. J. Robinson, C. F. Robertson, S. C. Ranganathan, et al. Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn Screening Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 146 - 152. [Abstract] [Full Text] [PDF]